Author

Qin Xiao

Vice Provost for Research & Professor of Pharmacology Albany College of Pharmacy and Health Sciences - Cited by 37,979 - cardiovascular pharmacology - hematology/oncology - drug discovery/drug development - vascular diseases - neuropharmacology

Biography

Dr Qin Xiao joined Hull University Business School as a senior lecturer in finance in February 2012, after lecturing in property at the University of Aberdeen for four and half years. She entered academia in February 2001, upon graduation with an MSc in Finance and Economics from the London School of Economics, and also worked briefly as a research analyst in the private sector. Dr Xiao completed her PhD in Economics at Nanyang Technological University whilst working full-time as a lecturer in economics there.
Title
Cited by
Year
Necroptosis in Alzheimer’s disease: Potential therapeutic target
R Richard, S MousaBiomedicine & Pharmacotherapy 152, 113203, 2022202
10
2022
Clinical application of nano-targeting for enhancing chemotherapeutic efficacy and safety in cancer management
MC Phillips, SA MousaNanomedicine 17 (6), 405-421, 2022202
9
2022
Curcumin and thymoquinone combination attenuates breast cancer cell lines’ progression
AA Saddiq, AH El-Far, SA Mohamed, OA Almaghrabi, SA MousaIntegrative Cancer Therapies 21, 15347354221099537, 2022202
6
2022
Curcumin, thymoquinone, and 3, 3′-diindolylmethane combinations attenuate lung and liver cancers progression
AA Saddiq, AH El-Far, SA Mohamed Abdullah, K Godugu, OA Almaghrabi, ...Frontiers in Pharmacology 13, 9399, 2022202
6
2022
Three-dimensional (3D) cell culture: A valuable step in advancing treatments for human hepatocellular carcinoma
AF Khafaga, SA Mousa, L Aleya, MM Abdel-DaimCancer Cell International 22 (1), 1-11, 2022202
4
2022
Intranasal delivery in glioblastoma treatment: prospective molecular treatment modalities
DE Morales, SA MousaHeliyon, 2022202
4
2022
Photochemoprevention of ultraviolet Beam Radiation-induced DNA damage in keratinocytes by topical delivery of nanoformulated Epigallocatechin-3-gallate
TA Salaheldin, VM Adhami, K Fujioka, H Mukhtar, SA MousaNanomedicine: Nanotechnology, Biology and Medicine , 102580, 2022202
4
2022
Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Retraction]
SA Loutfy, MH Elberry, KY Farroh, HT Mohamed, AA Mohamed, ...International Journal of Nanomedicine 17, 2891-2892, 2022202
3
2022
Effects of anticancer agent p-bi-TAT on gene expression link the integrin thyroid hormone receptor to expression of stemness and energy metabolism genes in cancer cells
GV Glinsky, K Godugu, T Sudha, M Rajabi, SV Chittur, AA Hercbergs, ...Metabolites 12 (4), 25, 2022202
3
2022
Natural bioactive compounds-doxorubicin combinations targeting topoisomerase II-alpha: Anticancer efficacy and safety
A Elfadadny, RF Ragab, R Hamada, SK Al Jaouni, J Fu, SA Mousa, H AliToxicology and Applied Pharmacology, 116405, 20220
3
2023
Pomegranate nanoparticle mitigates cisplatin-induced testicular toxicity and improves cisplatin anti-cancer efficacy in Ehrlich carcinoma model
M Qari, S Harakeh, IO Akefe, SH Saber, R Al-Raddadi, ZY Abd Elmageed, ...Journal of King Saud University-Science 35 (4), 10631, 030
2
2023
Pharmacokinetics of fluorobenzyl polyethylene glycol conjugated tetraiodothyroacetic acid (NP751), a novel anticancer thyrointegrin αvβ3 antagonist
K Fujioka, BA Hay, K Godugu, SA MousaFrontiers in Pharmacology 13, 90141, 0
2
2022
Composition and method for dual targeting in treatment of neuroendocrine tumors
S Mousa, M Rajabi, OO KarakusUS Patent 11,351,137, 0
2
2022
Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic …
T Sudha, K Godugu, GV Glinsky, SA MousaBiomedicines 10 (4), 795, 0
2
2022
Essence aromatique du Géranium Odorant (Pelargonium graveolens L’Hérit.) d’Algérie: Exploration des propriétés antioxydante, anti-inflammatoire et anticancéreuse (anti …
MN Boukhatem, T Sudha, NHE Darwish, HG Nada, SA MousaAnnales Pharmaceutiques Françaises 80 (3), 383-396, 0
2
2022
Future regenerative medicine developments and their therapeutic applications
AE Altyar, A El-Sayed, A Abdeen, M Piscopo, SA Mousa, A Najda, ...Biomedicine & Pharmacotherapy 158, 114131, 030
2
2023
Photochemical effect of silver nanoparticles on flesh fly larval biological system
MM Ali, MA Ramadan, NA Ghazawy, A Afify, SA MousaActa Histochemica 14 (3), 151871, 0
2
2022
Genetic Interpretation of the Impacts of Honokiol and EGCG on Apoptotic and Self-Renewal Pathways in HEp-2 Human Laryngeal CD44high Cancer Stem Cells
R Ashry, M Elhussiny, H Abdellatif, O Elkashty, HA Abdel-Ghaffar, ...Nutrition and Cancer 74 (6), 252-273, 2022202
1
2022
Aspirin and omega-3 polyunsaturated fatty acid use and their interaction in cardiovascular diseases and colorectal adenomas
IE Wang, S Yi, RC Block, SA MousaNutrition Research Reviews 35 (2), 295-307, 2022202
1
2022
Preclinical evaluation of triiodothyronine nanoparticles as a novel therapeutic intervention for resuscitation from cardiac arrest
BR Weil, SE Allen, T Barbaccia, K Wong, AM Beaver, EA Slabinski, ...Resuscitation 86, 09735, 2023202
1
2023

Referred From: https://scholar.google.com/citations?user=2I0AaNoAAAAJ&hl=en

Cited by
Citations 37979
h-index 95
i10-index 520
Recommended Journals
Open Access Journals